Novartis Boosts its Oncology Position
By Taskin Ahmed
PharmaDeals Review: Vol 2009 Issue 12 (Table of Contents)
Published: 4 Dec-2009
DOI: 10.3833/pdr.v2009i12.1280 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Novartis has acquired the rights to two investigational drugs from Incyte Corp indicated for myelofibrosis, blood disorders and cancer in a deal that could exceed US$1 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
RSS